The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Arrowhead Pharmaceuticals Inc shares valued at $774,975 were sold by Anzalone Christopher Richard on Mar 13 ’25. At $15.07 per share, Anzalone Christopher Richard sold 51,425 shares. The insider’s holdings dropped to 4,062,377 shares worth approximately $56.06 million following the completion of this transaction.
Also, Anzalone Christopher Richard purchased 51,425 shares, netting a total of over 774,785 in proceeds.
Before that, Anzalone Christopher Richard had sold 166,667 shares from its account. In a trade valued at $3,005,006, the Chief Executive Officer traded Arrowhead Pharmaceuticals Inc shares for $18.03 each. Upon closing the transaction, the insider’s holdings decreased to 166,667 shares, worth approximately $53.92 million.
As published in their initiating research note from Goldman on June 05, 2024, Arrowhead Pharmaceuticals Inc [ARWR] has been a Neutral and the price target has been revised to $31. Analysts at BofA Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in early December. As of September 19, 2023, Citigroup has initiated its “Neutral” rating for ARWR. Earlier on July 21, 2023, TD Cowen initiated its rating. Their recommendation was “an Outperform” for ARWR stock.
Analyzing ARWR Stock Performance
During the last five days, there has been a drop of approximately -8.67%. Over the course of the year, Arrowhead Pharmaceuticals Inc shares have dropped approximately -26.60%. Shares of the company reached a 52-week high of $21.84 on 02/07/25 and a 52-week low of $13.68 on 03/27/25. A 50-day SMA is recorded $18.21, while a 200-day SMA reached $21.51.
Support And Resistance Levels for Arrowhead Pharmaceuticals Inc (ARWR)
According to the 24-hour chart, there is a support level at 13.65, which, if violated, would cause prices to drop to 13.51. In the upper region, resistance lies at 13.97. The next price resistance is at 14.15. RSI (Relative Strength Index) is 31.62 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.88, which suggests the price will decrease in the coming days. Percent R is at 96.24%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
